Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Procter & Gamble Co (PG) vs Xpeng Inc - ADR (XPEV) Price & Performance

Procter & Gamble CoTrade
Xpeng Inc - ADRTrade

Price performance (Past 24H)

Key statistics

Procter & Gamble Co vs Xpeng Inc - ADR — how do they compare? Procter & Gamble Co trades at $143.48 (market cap $338.13B), while Xpeng Inc - ADR trades at $10.58 (market cap $10.34B). The key difference: Procter & Gamble Co is far larger — about 32.7× Xpeng Inc - ADR's market cap, and Procter & Gamble Co pays a 2.99% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.

PGXPEV
Market Cap
$338.13B$10.34B
Volume
6,423,436
Sector
Consumer StaplesConsumer Cyclical
52-Week High
$167.18$28.07
52-Week Low
$138.10$10.57
Enterprise Value
$363.97B$12.92B
Dividend Yield
2.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Procter & Gamble Co

Procter & Gamble (PG) trades at $145.59, down 0.57% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $1.89. Fundamentals show robust profitability, including a net income margin of 18.44% and ROE of 30.13%, though valuation ratios like P/E of 21.99 and P/S of 4.05 are at premiums to peers. Recent news highlights PG's dividend reliability and supply chain enhancements.

PG offers stability with consistent dividend growth and solid cash flows, but premium valuation and soft demand outlook pose near-term risks. Analyst consensus is bullish with a $161.20 price target, though technical weakness suggests potential consolidation. Key risks include economic sensitivity and competitive pressures, while institutional activity shows mixed positioning.

Xpeng Inc - ADR

XPeng (XPEV) trades at $10.93, down 0.18% on the day, with a bearish technical signal and negative earnings in recent quarters. The company reported a net loss of $1.14 billion in 2025 despite revenue growth to $76.72 billion, and cash flow trends show volatility. Recent news highlights expansion into humanoid robotics, with the robotics unit raising over $900 million at a $6.3 billion valuation in August 2026.

The outlook is mixed: analyst consensus is bullish with a $19.00 price target, but execution risks in the competitive EV market and persistent losses pose challenges. Robotics diversification offers long-term potential, yet near-term profitability remains uncertain amid weak delivery forecasts and macroeconomic pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG

About Xpeng Inc - ADR

Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Read more on XPEV